| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $734K | +48.0% |
| R&D Expense | $12.1M | -34.8% |
| SG&A Expense | $10.6M | -23.4% |
| Operating Income | -$21.9M | +31.1% |
| Interest Expense | $14K | — |
| Net Income | -$21.2M | +33.1% |
| EPS (Basic) | -$11.85 | -1017.9% |
| EPS (Diluted) | -$11.85 | -1017.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.5M | -67.0% |
| Current Assets | $7.6M | -60.1% |
| Total Assets | $12.0M | -50.1% |
| Current Liabilities | $2.4M | +114.8% |
| Total Liabilities | $2.5M | +98.3% |
| Stockholders' Equity | $9.6M | -58.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +41.3% |
| Capital Expenditures | $95K | -93.9% |
| Investing Cash Flow | -$95K | +93.9% |
| Financing Cash Flow | $5.0M | -57.3% |
| Free Cash Flow | -$16.1M | +44.2% |